Volastra Therapeutics Announces Participation in 2022 Guggenheim Synthetic Lethality Day
May 12, 2022
NEW YORK, May 12, 2022 – Volastra Therapeutics, an oncology company focused on exploiting chromosomal...
Volastra
1361 Amsterdam Ave Suite 520
New York, NY 10027
Phone: (646) 344-1248
contactus@volastratx.com